Promino Nutritional Sciences Inc.
MUSLF
$0.03
-$0.01-18.54%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 199.21% | 11.06% | -46.66% | -9.01% | -49.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 199.21% | 11.06% | -46.66% | -9.01% | -49.80% |
| Cost of Revenue | -39.78% | -60.03% | -68.74% | -66.02% | -29.53% |
| Gross Profit | 91.73% | 81.67% | 76.35% | 71.86% | 22.76% |
| SG&A Expenses | -70.52% | -29.05% | 62.79% | 209.20% | 13.12% |
| Depreciation & Amortization | -- | -- | -- | -76.92% | -55.74% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -64.27% | -35.02% | 23.58% | 87.54% | 2.05% |
| Operating Income | 72.85% | 37.55% | -29.50% | -91.64% | -5.61% |
| Income Before Tax | 63.77% | 38.29% | -27.44% | -72.11% | 0.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 63.77% | 38.29% | -27.44% | -72.11% | 0.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.77% | 38.29% | -27.44% | -72.11% | 0.62% |
| EBIT | 72.85% | 37.55% | -29.50% | -91.64% | -5.61% |
| EBITDA | 87.23% | 45.70% | -29.63% | -92.08% | -5.67% |
| EPS Basic | 84.08% | 64.90% | 23.20% | -28.76% | 19.41% |
| Normalized Basic EPS | 84.83% | 66.97% | 29.45% | -37.71% | 13.17% |
| EPS Diluted | 84.08% | 64.90% | 23.20% | -28.76% | 19.41% |
| Normalized Diluted EPS | 84.83% | 66.97% | 29.45% | -37.71% | 13.17% |
| Average Basic Shares Outstanding | 70.91% | 60.81% | 46.40% | 12.93% | 80.23% |
| Average Diluted Shares Outstanding | 70.91% | 60.81% | 46.40% | 12.93% | 80.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |